Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by crow27on Feb 17, 2021 8:11pm
197 Views
Post# 32591991

RE:RE:RE:RE:Lesson Learned

RE:RE:RE:RE:Lesson LearnedSo lets say they have aprox 15 million still from the first raise and then 20 million from the Nuance deal in a upfront payment which is in ATE bank account already and lets say this deal today raises 40 million
So we are sitting on aprox 75 million dollars.
Dan had the chance to make this deal and he took it and I would have taken it too. Other partnering deals may come and that will only pad the cash in this company.
If for some reason Dan could not raise cash then we would have been s crewed and then the SP would tank.
We do not have a care in the world now and every investor wants to see that financial statement.
Follow the yellow brick road folks and it just got paved with gold.
You want to sell low tomorrow ...................... you will be sorry.
<< Previous
Bullboard Posts
Next >>